ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,519Medicare Part D Prescriptions Filled, Including Refills

Rank: 331 out of 2170

$587K Total Retail Price of All Prescriptions

Rank: 330 out of 2170

341 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 341 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 341 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 7,808 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 429 337 1 2
HYDROCODONE-ACETAMINOPHEN 375 289 S3 2 7
LISINOPRIL 258 216 3 3
SIMVASTATIN 240 155 4 1
LEVOTHYROXINE SODIUM 228 206 5 5
HYDROCHLOROTHIAZIDE 189 162 6 9
METFORMIN HCL ER 186 131 7 35
ATORVASTATIN CALCIUM 184 150 8 12
FUROSEMIDE 177 168 9 6
METOPROLOL SUCCINATE 167 113 10 13
WARFARIN SODIUM 163 137 11 15
POTASSIUM CHLORIDE 152 135 12 16
METOPROLOL TARTRATE 149 113 13 10
TRAZODONE HCL 138 105 14 38
ATENOLOL 129 98 15 23
FLUTICASONE PROPIONATE 127 73 16 30
LEVOXYL 122 108 17 115
NEXIUM 114 75 18 22
SERTRALINE HCL 108 65 19 25
PRAVASTATIN SODIUM 103 84 20 11
RANITIDINE HCL 102 93 21 40
LOSARTAN POTASSIUM 102 72 21 21
AMLODIPINE BESYLATE 101 90 23 4
BISOPROLOL-HYDROCHLOROTHIAZIDE 97 95 24 116
PROMETHAZINE HCL 96 53 R 25 70
RAMIPRIL 94 51 26 77
CARVEDILOL 93 69 27 26
PANTOPRAZOLE SODIUM 90 56 28 39
CLOPIDOGREL 88 73 29 37
CITALOPRAM HBR 87 57 30 19
MELOXICAM 83 53 31 28
METFORMIN HCL 81 65 32 8
TRAMADOL HCL 79 49 33 18
CLONIDINE HCL 75 64 34 54
AZITHROMYCIN 73 52 35 47
ALENDRONATE SODIUM 72 52 36 36
PREDNISONE 71 67 37 41
PLAVIX 70 61 38 58
DOXAZOSIN MESYLATE 70 48 38 93
DONEPEZIL HCL 66 66 40 32
ENALAPRIL MALEATE 65 62 41 64
CHLORTHALIDONE 63 42 42 166
SPIRIVA 60 41 43 49
DIGOXIN 59 59 44 72
LOVASTATIN 59 43 44 34
MIRTAZAPINE 57 40 46 46
ISOSORBIDE MONONITRATE ER 56 56 47 50
PHENYTOIN SODIUM EXTENDED 56 13 47 142
ALLOPURINOL 55 51 49 29
ZETIA 55 55 49 78
AMLODIPINE BESYLATE-BENAZEPRIL 54 54 51 67
ZOLPIDEM TARTRATE 54 16 51 17
DOXYCYCLINE HYCLATE 51 40 53 100
CEFUROXIME 51 33 53 175
ROPINIROLE HCL 51 39 53 92
LANTUS 51 51 53 51
CRESTOR 50 29 57 24
VERAPAMIL ER 50 26 57 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.